• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Marie Powers

Articles by Marie Powers

Value Creation is the Name of the Game in Bio Partnering

Sep. 20, 2012
By Marie Powers
BOSTON – From the welcoming remarks to the plenary session and workshops, the message to BioPharm America 2012 attendees was loud and clear: Partnering is all about value creation.
Read More

Pfizer Grows Generics Options with Joint Venture in China

Sep. 14, 2012
By Marie Powers
Pfizer Inc. staked its claim in China's growing generics market by joining Zhejiang Hisun Pharmaceutical Co. Ltd. to create Hisun-Pfizer Pharmaceuticals Co. Ltd.
Read More

NeuroNascent Aims to Reverse Neurodegenerative Damage

Sep. 13, 2012
By Marie Powers
A slew of recent failures in Alzheimer's disease (AD) could prove providential for NeuroNascent Inc., which has ambitious plans to halt and potentially reverse a range of neurodegenerative diseases.
Read More

Imetelstat Implodes in Breast Cancer Trial, Geron Swoons

Sep. 11, 2012
By Marie Powers
The melancholy on the Geron Corp. conference call early Monday morning was palpable after the company disclosed its decision to halt the Phase II study of imetelstat in metastatic HER2-negative breast cancer after an unplanned interim analysis revealed a greater number of deaths in the treatment arm than the comparator arm.
Read More

Fedora Turning Heads with Beta-Lactamase Inhibitors

Sep. 10, 2012
By Marie Powers
Newly launched Canadian biotech Fedora Pharmaceuticals Inc. has landed in the antibiotics space with multiple beta-lactamase inhibitor candidates in the lead optimization stage of preclinical development and investigational new drug-enabling studies expected to begin next year.
Read More

Kalidex to Emerge at ICAAC with Novel Fluoroquinolone

Sep. 7, 2012
By Marie Powers
Privately held Kalidex Pharmaceuticals Inc. is set to debut on the biotech stage with an oral presentation and two dozen posters on its broad-spectrum, next-generation fluoroquinolone, KPI-10, at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), which begins Sunday in San Francisco.
Read More

IPO Queue Heats Up with Intercept Pharma Filing

Sep. 5, 2012
By Marie Powers
Intercept Pharmaceuticals Inc. became the third biotech in three weeks to file an S-1 registration statement with the SEC for a proposed initial public offering (IPO), following Regulus Therapeutics Inc. and OvaScience Inc. into the queue.
Read More

Ironwood's Linzess Beats PDUFA Date to Approval in IBS

Sep. 5, 2012
By Marie Powers

Ironwood Pharmaceuticals Inc. crossed the commercial threshold Thursday morning, gaining FDA approval of irritable bowel syndrome (IBS) drug linaclotide more than a week ahead of the drug's Sept. 9 PDUFA date.

Read More

Inverseon, CBio Combine Programs in All-Stock Merger

Sep. 5, 2012
By Marie Powers
Australian drug developer CBio Ltd. acquired privately held Inverseon Inc. in an all-stock deal, creating Invion Ltd., which will operate from offices in San Francisco and Brisbane.
Read More

Ceptaris Seeking Success via Single-Asset Solution

Aug. 30, 2012
By Marie Powers
Going against the grain, Ceptaris Therapeutics Inc. is seeking to parlay a single asset in a rare form of cancer into both clinical and financial success.
Read More
Previous 1 2 … 140 141 142 143 144 145 146 147 148 … 168 169 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 25, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 25, 2025.
  • Blue injector pens

    Biocon wins first FDA interchangeable label of Novolog biosimilar

    BioWorld Asia
    The U.S. FDA on July 15 cleared Biocon Biologics Ltd.’s Kirsty (insulin aspart-xjhz) as the first and only interchangeable biosimilar product referencing Novo...
  • Brain and neural networks

    Proteomics finds surprise commonalities as well as differences in neurodegenerative diseases

    BioWorld
    The switch will be flicked today to make the world’s largest dementia-related proteomics dataset freely available to researchers, at the same time as members of...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 22, 2025
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe